The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Alexion Pharmaceuticals Inc

Nasdaq: ALXN
Last

(U.S.) $188.96

Today's change0.00 0.00%
Updated December 18 4:00 PM EST. Delayed by at least 15 minutes.
 

Alexion Pharmaceuticals Inc

Nasdaq: ALXN
Last

(U.S.) $188.96

Today's change0.00 0.00%
Updated December 18 4:00 PM EST. Delayed by at least 15 minutes.

Alexion Pharmaceuticals Inc closed at (U.S.)$188.96.

Shares have lost 1.39% over the last five days, but have gained 42.20% over the last year to date. This security has outperformed the S&P 500 by 33.04% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $188.96
  • High--
  • Low--
  • Bid / Ask(U.S.) $177.25 / (U.S.) $195.27
  • YTD % change+42.20%
  • Volume0
  • Average volume (10-day)1,276,391
  • Average volume (1-month)1,041,420
  • Average volume (3-month)1,190,178
  • 52-week range(U.S.) $122.69 to (U.S.) $203.30
  • Beta0.74
  • Trailing P/E78.63×
  • P/E 1 year forward36.32×
  • Forward PEG1.18×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.40
Updated December 18 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue555512567442
Total other revenue--------
Total revenue555512567442
Gross profit503473534390
Total cost of revenue52403352
Total operating expense318294357304
Selling / general / administrative158159129135
Research & development978918883
Depreciation / amortization3333
Interest expense (income), net operating--------
Unusual expense (income)82332
Other operating expenses, total--------
Operating income237219210138
Interest income (expense), net non-operating-----1-1
Gain (loss) on sale of assets--------
Other--------
Income before tax236219212138
Income after tax178166159-19
Income tax, total585253157
Net income178166159-19
Total adjustments to net income--------
Net income before extra. items178166159-19
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items178166159-19
Inc. avail. to common incl. extra. items178166159-19
Diluted net income178166159-19
Dilution adjustment00--0
Diluted weighted average shares201202202199
Diluted EPS excluding extraordinary itemsvalue per share0.880.830.79-0.10
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.910.830.800.01